BioVersys AG (SWX:BIOV)
Switzerland
· Delayed Price · Currency is CHF 29.90
+0.40 (1.36%)
Last updated: Apr 28, 2026, 4:36 PM CET
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 174.86 million as of April 28, 2026. Its market cap has decreased by -16.59% in one year.
Market Cap
174.86M
Enterprise Value
114.08M
Revenue
3.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.90
Market Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 174.86M, a decrease of -15.90%. That is a compound annual growth rate of -13.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 174.86M | 22.54% |
| Dec 30, 2025 | 142.69M | -31.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xlife Sciences AG | 122.85M |
| Molecular Partners AG | 122.34M |
| Santhera Pharmaceuticals Holding AG | 235.92M |
| Newron Pharmaceuticals | 324.15M |
| MindMaze Therapeutics Holding | 45.93M |
| Basilea Pharmaceutica AG | 651.45M |
| Idorsia | 945.16M |
| EvoNext Holdings | 7.07M |